Evaluation of Propess outcomes for cervical ripening and induction of labour in full-term pregnancy

被引:14
作者
Chen, W. [1 ]
Zhou, Y. [1 ]
Pu, X. [1 ]
Xiao, C. [1 ]
机构
[1] Shanghai Changning Matern & Infant Hlth Hosp, Dept Obstet, Shanghai 200051, Peoples R China
关键词
Cervical ripening; induction of labour; oxytocin; Propess; DINOPROSTONE VAGINAL INSERT; PROSTAGLANDIN E-2; RANDOMIZED-TRIAL; MISOPROSTOL; OXYTOCIN; EFFICACY;
D O I
10.3109/01443615.2013.853730
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This study was to investigate the efficiency and safety of vaginal Propess as a methodology for cervical ripening and labour induction in full-term pregnant patients. Women at term with a Bishop's score of < 6 and without any contraindications, to vaginal delivery, or the use of prostaglandin or oxytocin in induction of labour, were divided into three groups: oxytocin group (n = 59), intact membranes (Propess I group; n = 58) and natural rupture (Propess R group; n = 52) groups. The main outcome measures, including change in Bishop's score, induction to delivery interval, total delivery time, rate of vaginal delivery, fetal outcome and maternal complications during induction, were recorded. In the Propess groups, the Bishop's score and rate of vaginal delivery were significantly higher while the induction to delivery interval and total delivery time were much shorter, as compared with oxytocin patients (p < 0.01). There were no significant differences in fetal and maternal outcome during induction between the Propess groups and oxytocin group (p > 0.05). In addition, there were no significant differences of Bishop's score, rate of vaginal delivery, induction to delivery interval and total delivery time between the Propess I group and Propess R group (p > 0.05). Propess is an effective and safe approach to promote cervical ripening and be successfully used in induction of labour.
引用
收藏
页码:255 / 258
页数:4
相关论文
共 19 条
[1]   Intravenous oxytocin alone for cervical ripening and induction of labour [J].
Alfirevic, Zarko ;
Kelly, Anthony J. ;
Dowswell, Therese .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04)
[2]  
Beebe LA, 2000, J REPROD MED, V45, P469
[3]   Labor induction: Historic perspectives [J].
Benrubi, GI .
CLINICAL OBSTETRICS AND GYNECOLOGY, 2000, 43 (03) :429-432
[4]  
Bezircioglu I, 2012, CLIN EXP OBSTET GYN, V39, P356
[5]  
CALDER A, 1997, J OBSTET GYNAECOL, V17, P53
[6]   Randomized trial of concurrent oxytocin with a sustained-release dinoprostone vaginal insert for labor induction at term [J].
Christensen, FC ;
Tehranifar, M ;
Gonzalez, JL ;
Qualls, CR ;
Rappaport, VJ ;
Rayburn, WF .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (01) :61-65
[7]   The epidemiology of labor induction: Arizona, 1997 [J].
Coonrod, DV ;
Bay, RC ;
Kishi, GY .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (06) :1355-1360
[8]   Cervical ripening and labor induction: Clinical guidelines [J].
Hadi, H .
CLINICAL OBSTETRICS AND GYNECOLOGY, 2000, 43 (03) :524-536
[9]   Current pharmacotherapy options for labor induction [J].
Hawkins, J. Seth ;
Wing, Deborah A. .
EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (14) :2005-2014
[10]  
Leszczynska-Gorzelak B, 2001, Med Sci Monit, V7, P1023